REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
RNS Number : 8792JBank of America Merrill Lynch16 April 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
09/04/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
178,955
0.037%
2,445,568
0.166 %
(2)
Derivatives (other than options):
1,923,977
0.127%
149,338
0.035%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,110,332
0.143%
2,602,406
0.176%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
5,196
79.74 USD
Purchase
421,635
78.56 USD
Purchase
100
78.82 USD
Purchase
200
78.83 USD
Purchase
2
78.89 USD
Purchase
100
78.92 USD
Purchase
2
78.98 USD
Purchase
100
79 USD
Purchase
151
79.01 USD
Purchase
22
79.02 USD
Purchase
87
79.05 USD
Purchase
277
79.07 USD
Purchase
191
79.08 USD
Purchase
467
79.1 USD
Purchase
495
79.11 USD
Purchase
673
79.12 USD
Purchase
556
79.13 USD
Purchase
127
79.14 USD
Purchase
86
79.15 USD
Purchase
363
79.16 USD
Purchase
114
79.17 USD
Purchase
115
79.18 USD
Purchase
34
79.19 USD
Purchase
70
79.2 USD
Purchase
374
79.21 USD
Purchase
104
79.22 USD
Purchase
253
79.25 USD
Purchase
888
79.26 USD
Purchase
361
79.27 USD
Purchase
514
79.28 USD
Purchase
152
79.29 USD
Purchase
87
79.3 USD
Purchase
94
79.31 USD
Purchase
286
79.32 USD
Purchase
386
79.33 USD
Purchase
238
79.34 USD
Purchase
673
79.35 USD
Purchase
419
79.36 USD
Purchase
333
79.37 USD
Purchase
310
79.38 USD
Purchase
302
79.39 USD
Purchase
455
79.4 USD
Purchase
488
79.41 USD
Purchase
359
79.42 USD
Purchase
101
79.43 USD
Purchase
731
79.44 USD
Purchase
916
79.45 USD
Purchase
27
79.46 USD
Purchase
121
79.47 USD
Purchase
558
79.48 USD
Purchase
1,169
79.49 USD
Purchase
716
79.5 USD
Purchase
823
79.51 USD
Purchase
785
79.52 USD
Purchase
710
79.53 USD
Purchase
309
79.54 USD
Purchase
488
79.55 USD
Purchase
1,003
79.56 USD
Purchase
502
79.57 USD
Purchase
1,243
79.58 USD
Purchase
86
79.585 USD
Purchase
748
79.59 USD
Purchase
1,166
79.6 USD
Purchase
1
79.605 USD
Purchase
879
79.61 USD
Purchase
1,236
79.62 USD
Purchase
136
79.627 USD
Purchase
1,500
79.63 USD
Purchase
599
79.64 USD
Purchase
1,250
79.65 USD
Purchase
739
79.66 USD
Purchase
456
79.67 USD
Purchase
307
79.68 USD
Purchase
364
79.69 USD
Purchase
169
79.7 USD
Purchase
371
79.71 USD
Purchase
802
79.72 USD
Purchase
1,197
79.73 USD
Purchase
444
79.74 USD
Purchase
33,899
79.75 USD
Purchase
517
79.76 USD
Purchase
92
79.77 USD
Purchase
408
79.78 USD
Purchase
994
79.79 USD
Purchase
580
79.8 USD
Purchase
561
79.81 USD
Purchase
453
79.82 USD
Purchase
244
79.83 USD
Purchase
4,226
79.84 USD
Purchase
288
79.85 USD
Purchase
183
79.86 USD
Purchase
442
79.87 USD
Purchase
143
79.88 USD
Purchase
159
79.89 USD
Purchase
141
79.9 USD
Purchase
267
79.91 USD
Purchase
358
79.92 USD
Purchase
329
79.93 USD
Purchase
157
79.94 USD
Purchase
147
79.95 USD
Purchase
63
79.96 USD
Purchase
291
79.97 USD
Purchase
146
79.98 USD
Purchase
63
79.99 USD
Purchase
165
80 USD
Purchase
129
80.02 USD
Purchase
3
80.03 USD
Purchase
100
80.04 USD
Purchase
100
80.06 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
421,599
78.56 USD
Sale
3
78.82 USD
Sale
3
78.92 USD
Sale
99
78.99 USD
Sale
3
79.04 USD
Sale
4
79.05 USD
Sale
101
79.06 USD
Sale
159
79.061 USD
Sale
3
79.07 USD
Sale
3
79.14 USD
Sale
3
79.15 USD
Sale
7
79.16 USD
Sale
3
79.17 USD
Sale
3
79.18 USD
Sale
263
79.2 USD
Sale
113
79.201 USD
Sale
204
79.23 USD
Sale
259
79.25 USD
Sale
200
79.26 USD
Sale
215
79.28 USD
Sale
484
79.29 USD
Sale
290
79.3 USD
Sale
65
79.33 USD
Sale
86
79.34 USD
Sale
88
79.35 USD
Sale
57
79.36 USD
Sale
259
79.37 USD
Sale
616
79.4 USD
Sale
104
79.41 USD
Sale
566
79.42 USD
Sale
120
79.43 USD
Sale
479
79.44 USD
Sale
460
79.45 USD
Sale
480
79.46 USD
Sale
100
79.465 USD
Sale
367
79.47 USD
Sale
206
79.48 USD
Sale
100
79.485 USD
Sale
260
79.49 USD
Sale
190
79.5 USD
Sale
364
79.51 USD
Sale
662
79.52 USD
Sale
1,019
79.53 USD
Sale
648
79.54 USD
Sale
801
79.55 USD
Sale
504
79.56 USD
Sale
418
79.57 USD
Sale
449
79.58 USD
Sale
100
79.595 USD
Sale
273
79.6 USD
Sale
282
79.61 USD
Sale
803
79.62 USD
Sale
570
79.63 USD
Sale
1,544
79.64 USD
Sale
100
79.645 USD
Sale
336
79.65 USD
Sale
1,145
79.66 USD
Sale
402
79.67 USD
Sale
27
79.679 USD
Sale
200
79.68 USD
Sale
101
79.69 USD
Sale
232
79.7 USD
Sale
339
79.71 USD
Sale
810
79.72 USD
Sale
101
79.73 USD
Sale
394
79.74 USD
Sale
10,546
79.75 USD
Sale
1,253
79.76 USD
Sale
511
79.77 USD
Sale
469
79.78 USD
Sale
262
79.79 USD
Sale
522
79.8 USD
Sale
760
79.81 USD
Sale
474
79.82 USD
Sale
87
79.83 USD
Sale
3,757
79.84 USD
Sale
658
79.85 USD
Sale
685
79.86 USD
Sale
502
79.87 USD
Sale
2
79.871 USD
Sale
4
79.88 USD
Sale
64
79.89 USD
Sale
202
79.9 USD
Sale
87
79.92 USD
Sale
1
79.93 USD
Sale
109
79.94 USD
Sale
1
79.95 USD
Sale
173
79.96 USD
Sale
86
79.97 USD
Sale
62
79.98 USD
Sale
273
79.99 USD
Sale
8,006
79.75 USD
Sale
100
79.83 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Opening a long position
27
79.678 USD
Swaps
Increasing a long position
10,198
79.746 USD
Swaps
Reducing a long position
58,338
78.56 USD
Swaps
Closing a Short Position
2,326
79.75 USD
Swaps
Reducing a short position
2,985
79.75 USD
Swaps
Reducing a long position
20,669
79.75 USD
Swaps
Increasing a short position
363,261
78.56 USD
Swaps
Reducing a long position
136
79.651 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
N/A
N/A
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
16/04/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEFIFIASFIRLII
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement